Third Frontier Commits more than $4.4M to Foster Region’s Growing Biomedical and Medical Imaging Projects

The Ohio Third Frontier announced this week it plans to invest more than $4.4 million in Central Ohio companies and projects within the biomedical and advanced medical imaging industries.  This funding is part of an announced $14.9 million statewide funding round from the Ohio Third Frontier Biomedical and Medical Imaging Programs. 

Dublin-based Cardiox Corp, in collaboration with Nottingham Spirk Design Associates and QTest Labs, was awarded $986,373 for its Validation and Commercialization of Non-Invasive Detection of Cardiox Shunts project. The project will finalize designs and clinical protocols for a new method for detecting congenital right-to-left shunts or “holes in the heart”. The presence of right-to-left shunts significantly increases the danger of strokes. Recently developed minimally invasive procedures can close the hole, however current detection requires expensive equipment and highly trained personnel. The Cardiox technology provides a low- cost alternative method of detecting and quantifying the shunt. 

EXCMR, Ltd., headquartered in the TechColumbus incubator, in collaboration with the Cleveland Clinic, University Hospitals Case Medical Center, Christ Hospital, The Ohio State University, Quality Electrodynamics, Siemens Medical Solutions, Heart Imaging Technologies, and Zukun Plan, was awarded $1,424,694 for its In-State Multi-Center Evaluation of Treadmill Exercise Stress Cardiac Magnetic Resonance project. The project will support clinical testing and refinement of technology to improve cardiac magnetic resonance imaging under stress conditions. Cardiac stress induced by exercise instead of drugs is a more realistic test in cardiac imaging. The advanced hydraulic treadmill without an electric motor and steel parts – which interfere with the MRI – will be tested in clinical settings. 

Lanx, Inc., currently located in the City of Broomfield, CO, in collaboration with The Ohio State University, OrthoNeuro, Cleveland Clinic, Ohio Spine Network, American Medical Management, KB Medical, and RBK Spine LLC, was awarded $1 million for its Lumbar Motion Monitor Commercialization in Ohio project. The project will form a new Ohio-based division located in Columbus to finalize the design and commercialization of a device to measure range of lumbar motion in patients with back injuries. The new device will provide physicians with more detailed, objective information to more accurately diagnose the location and extent of injury to enable more effective treatment. 

Neoprobe Corporation, located in Dublin, in collaboration with Cardinal Health, STATKING Consulting, Phylogeny, Inc., and Integrated BioScience Solutions, was awarded $1 million for its Phase III Clinical Study Supporting Expanded FDA Claims for Lymphoseek, A Medical Imaging Agent for Sentinel Lymph Node Mapping in Breast Cancer, Melanoma, and Head and Neck Cancer project. The project will accelerate the clinical study of the radiopharmaceutical imaging agent Lymphoseek, which is used to improve the detection of cancer in lymph nodes.

For more information, see the releases from the Ohio Third Frontier:

Ohio Third Frontier Awards Support the State’s Growing Biomedical Industry

Ohio Third Frontier Awards Support the State’s Growing Medical Imaging Industry